Studies show that NF-κB is expressed more aggressively in a number of cancers with an epithelial origin and that structurally activated NF-κB is closely associated with epithelial-derived tumours, such as squamous cell carcinoma8, colorectal cancer9, BC10 and renal cell carcinoma11. Here, NFKB1 is linked to cancer.